Moderna stock rises following RFK Jr's comments

Investing.com -- Shares of Moderna Inc (NASDAQ: MRNA) climbed 5.4% mid-day Tuesday as remarks by RFK Jr, who clarified his stance as not being anti-vaccine or anti-industry, appeared to bolster investor confidence. The biotechnology company's stock movement comes alongside gains in other industry players such as Novavax, Inc. (NASDAQ: NVAX), BioNTech SE (NASDAQ: BNTX), and Pfizer Inc. (NYSE: PFE).

The rise in Moderna's stock indicates a positive market response, which may be attributed to the broader perception of support for vaccine makers following RFK Jr's comments. This sentiment seems to be extending across the sector, with notable upticks in the shares of Novavax, BioNTech, and Pfizer as well.

You May Also Be Interested In

• Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg
• Venu Holding enters $250 million at-the-market stock offering agreement
• XORTX to voluntarily delist from TSX Venture Exchange